Form EFFECT KIORA PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 19, 2025 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kiora Pharmaceuticals (KPRX) Tops Q2 EPS by 17c
- CGX Energy Files June 30, 2026 Financial Statements and Announces Changes to the Board of Directors
- Dogecoin Price Prediction: $1 DOGE Would Need a $155B Market Cap as AlphaPepe Buyers Hunt the Smaller-Cap 100x Setup
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
